AstraZeneca Launches Health-Tech Business Evinova
Portfolio Pulse from Charles Gross
AstraZeneca has launched Evinova, a new health-tech business providing digital health solutions to healthcare professionals, regulators, and patients. Evinova, backed by AstraZeneca, will collaborate with Parexel and Fortrea to offer its services globally to the life sciences and healthcare sector. It aims to support clinical trial sponsors, CROs, clinical trial site care teams, and patients with evidence-led, science-based, and human experience-driven digital products.
November 20, 2023 | 10:04 am
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
AstraZeneca's launch of Evinova, a health-tech business, could enhance its service offerings in the digital health space and potentially open new revenue streams through partnerships with Parexel and Fortrea.
The launch of Evinova represents a strategic expansion for AstraZeneca into the digital health sector, which is a growing market. The backing of AstraZeneca and the strategic collaborations with Parexel and Fortrea suggest a strong commitment to the success of this venture. This could lead to positive investor sentiment in the short term, as it demonstrates AstraZeneca's diversification and innovation in healthcare solutions.
CONFIDENCE 80
IMPORTANCE 75
RELEVANCE 90